Long-term remission with rituximab in refractory leucine-rich glioma inactivated 1 antibody encephalitis

被引:27
作者
Brown, J. William L. [1 ]
Martin, Peter J. [1 ]
Thorpe, John W. [1 ]
Michell, Andrew W. [1 ]
Coles, Alasdair J. [1 ]
Cox, Amanda L. [1 ]
Vincent, Angela [2 ]
Zandi, Michael S. [1 ]
机构
[1] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 2QQ, England
[2] John Radcliffe Hosp, Neurosci Grp, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England
关键词
VGKC; LGI1; Autoantibody; Rituximab; Encephalitis; Cognition;
D O I
10.1016/j.jneuroim.2014.03.012
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Autoinimune encephalitis associated with antibodies to leucine-rich glioma inactivated 1 (LGI1) is recently described and there is a lack of detailed reports on the treatment of relapsing or refractory cases and long-term outcomes. Two case reports are presented. Both cases had faciobrachial dystonic seizures (FBDS) and received rituximab after relapsing or refractory disease. Both cases achieved sustained clinical remission of up to 15 and 56 months respectively. Rituximab use allowed withdrawal of corticosteroids and was well tolerated. Randomized clinical trials are needed in LGI1 encephalitis and other autoimmune encephalitides. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:66 / 68
页数:3
相关论文
共 12 条
[1]   Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus [J].
Anolik, JH ;
Barnard, J ;
Cappione, A ;
Pugh-Bernard, AE ;
Felgar, RE ;
Looney, RJ ;
Sanz, I .
ARTHRITIS AND RHEUMATISM, 2004, 50 (11) :3580-3590
[2]   Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis [J].
Edwards, JCW ;
Szczepanski, L ;
Szechinski, J ;
Filipowicz-Sosnowska, A ;
Emery, P ;
Close, DR ;
Stevens, RM ;
Shaw, T .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (25) :2572-2581
[3]   Anti-B Cell Antibody Therapies for Inflammatory Rheumatic Diseases [J].
Faurschou, Mikkel ;
Jayne, David R. W. .
ANNUAL REVIEW OF MEDICINE, VOL 65, 2014, 65 :263-278
[4]  
Irani S.R., 2013, BRAIN
[5]   Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia [J].
Irani, Sarosh R. ;
Alexander, Sian ;
Waters, Patrick ;
Kleopa, Kleopas A. ;
Pettingill, Philippa ;
Zuliani, Luigi ;
Peles, Elior ;
Buckley, Camilla ;
Lang, Bethan ;
Vincent, Angela .
BRAIN, 2010, 133 :2734-2748
[6]   Rituximab in the treatment of three coexistent neurological autoimmune diseases: chronic inflammatory demyelinating polyradiculoneuropathy, Morvan syndrome and myasthenia gravis [J].
Sadnicka, Anna ;
Reilly, Mary M. ;
Mummery, Cath ;
Brandner, Sebastian ;
Hirsch, Nicholas ;
Lunn, Michael P. T. .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2011, 82 (02) :230-232
[7]   VGKC-complex/LGI1-antibody encephalitis: Clinical manifestations and response to immunotherapy [J].
Shin, Yong-Won ;
Lee, Soon-Tae ;
Shin, Jung-Won ;
Moon, Jangsup ;
Lim, Jung-Ah ;
Byun, Jung-Ick ;
Kim, Tae-Joon ;
Lee, Keon-Joo ;
Kim, Young-Su ;
Park, Kyung-Il ;
Jung, Keun-Hwa ;
Lee, Sang Kun ;
Chu, Kon .
JOURNAL OF NEUROIMMUNOLOGY, 2013, 265 (1-2) :75-81
[8]   Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis - Remission, relapse, and re-treatment [J].
Smith, K. G. C. ;
Jones, R. B. ;
Burns, S. M. ;
Jayne, D. R. W. .
ARTHRITIS AND RHEUMATISM, 2006, 54 (09) :2970-2982
[9]   Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study [J].
Titulaer, Maarten J. ;
McCracken, Lindsey ;
Gabilondo, Inigo ;
Armangue, Thais ;
Glaser, Carol ;
Iizuka, Takahiro ;
Honig, Lawrence S. ;
Benseler, Susanne M. ;
Kawachi, Izumi ;
Martinez-Hernandez, Eugenia ;
Aguilar, Esther ;
Gresa-Arribas, Nuria ;
Ryan-Florance, Nicole ;
Torrents, Abiguei ;
Saiz, Albert ;
Rosenfeld, Myrna R. ;
Balice-Gordon, Rita ;
Graus, Francesc ;
Dalmau, Josep .
LANCET NEUROLOGY, 2013, 12 (02) :157-165
[10]   Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis [J].
Vincent, A ;
Buckley, C ;
Schott, JM ;
Baker, I ;
Dewar, BK ;
Detert, N ;
Clover, L ;
Parkinson, A ;
Bien, CG ;
Omer, S ;
Lang, B ;
Rossor, MN ;
Palace, J .
BRAIN, 2004, 127 :701-712